Pharmaceutical industry executives, speaking confidentially, paint a frank picture of the rationale behind the price of medication available to people with multiple sclerosis.
from Latest Science News -- ScienceDaily https://ift.tt/33o3DEw
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment